FDA Pediatric Advisory Committee Unanimously Votes YES — Now Moves to Commissioner

Today ’s Pediatric Advisory Committee Meeting resulted in a unanimous decision from committee members to recommend the use of in-dwelling ports in Sarepta's ESSENCE clinical trial. A final decision will be announced once the Commissioner has reviewed the summary report.
Source: Parent Project Muscular Dystrophy - Category: Neurology Source Type: news